Congenital Hyperinsulinism Treatment Market is Set to Exhibit High...

adicionou um novo artigo Health

2024-06-05 13:40:44

Congenital Hyperinsulinism Treatment Market is Set to Exhibit High Growth Due to Advancements in Genetic Testing

The congenital hyperinsulinism treatment market encompasses drugs and devices used for managing congenital hyperinsulinism, an autosomal dominant disease characterized by dysregulated insulin secretion. The treatment involves use of diazoxide to inhibit insulin secretion andoctreotide to delay gastric emptying. Surgery including partial pancreatectomy is performed in severe cases. The global...

0 Comentários 0 Compartilhamentos 386 Visualizações